Invention Grant
US08980244B2 Method of treating type 1 diabetes by administering NKp46 polypeptide
有权
通过施用NKp46多肽治疗1型糖尿病的方法
- Patent Title: Method of treating type 1 diabetes by administering NKp46 polypeptide
- Patent Title (中): 通过施用NKp46多肽治疗1型糖尿病的方法
-
Application No.: US13862927Application Date: 2013-04-15
-
Publication No.: US08980244B2Publication Date: 2015-03-17
- Inventor: Ofer Mandelboim , Angel Porgador , Yaakov Naparstek , Chamutal Gur
- Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. , Hadasit Medical Research Services and Development Ltd. , Ben-Gurion University of the Negev Research and Development Authority
- Applicant Address: IL Beer Sheva IL Jerusalem IL Jerusalem
- Assignee: Ben-Gurion University of the Negev Research and Development Authority,Hadasit Medical Research Services and Development Ltd.,Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
- Current Assignee: Ben-Gurion University of the Negev Research and Development Authority,Hadasit Medical Research Services and Development Ltd.,Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd.
- Current Assignee Address: IL Beer Sheva IL Jerusalem IL Jerusalem
- Agency: Browdy and Neimark, PLLC
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K39/395 ; C07K16/28 ; C07K14/705 ; A61P3/10 ; A61K39/00 ; A61K38/00
Abstract:
The invention relates to use of the natural cytotoxicity receptor NKp46 for preventing and treating diabetes, including type I diabetes (TID) and type 2 diabetes. In particular, the invention provides compositions comprising a fragment of the extracellular region of NKp46 for preventing the onset and progression of diabetes.
Public/Granted literature
- US20130280209A1 METHOD FOR TREATING TYPE 1 DIABETES Public/Granted day:2013-10-24
Information query
IPC分类:
